[{"Assets_0_Q1_USD":2436900.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-2134100.0,"NetIncomeLoss_1_Q1_USD":-2265300.0,"StockholdersEquity_0_Q1_USD":-606800.0,"Ticker":"VTGN","CIK":"1411685","name":"VISTAGEN THERAPEUTICS, INC.","OfficialName":"VistaGen Therapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"309791933.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170814"}]